Century Therapeutics
Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.
About Century Therapeutics
Century Therapeutics builds an allogeneic iPSC-derived cell therapy platform that integrates gene editing, protein engineering, technical development, and manufacturing capabilities to generate allogeneic, iPSC-derived NK and T cell therapies for both hematological and solid tumor malignancies with significant unmet medical needs.
Company Facts
- Headquarters
- Philadelphia
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00101_00250
- Funding Stage
- ipo
- Total Funding
- $755,000,000
- Last Funding Type
- post_ipo_equity
- Last Funding Date
- 2026-01-08
- Website
- centurytx.com
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Links
Canonical: https://fsome.com/organization/century-therapeutics-11146 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.